PuSH - Publikationsserver des Helmholtz Zentrums München: Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO).

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Mikolajczyk, R.* ; Diexer, S.* ; Klee, B.* ; Pfrommer, L.* ; Purschke, O.* ; Fricke, J.* ; Ahnert, P.* ; Gabrysch, S.* ; Gottschick, C.* ; Bohn, B.* ; Brenner, H.* ; Buck, C.* ; Castell, S.* ; Gastell, S.* ; Greiser, K.H.* ; Harth, V.* ; Heise, J.K.* ; Holleczek, B.* ; Kaaks, R.* ; Keil, T.* ; Krist, L.* ; Leitzmann, M.* ; Lieb, W.* ; Meinke-Franze, C.* ; Michels, K.B.* ; Velásquez, I.M.* ; Obi, N.* ; Panreck, L.* ; Peters, A. ; Pischon, T.* ; Schikowski, T.* ; Schmidt, B.* ; Standl, M. ; Stang, A.* ; Völzke, H.* ; Weber, A.* ; Zeeb, H.* ; Karch, A.*

Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO).

J. Infect. 89, 7:106206 (2024)

Verlagsversion

DOI

PMC

	Open Access Hybrid

Abstract
Metriken
Zusatzinfos

OBJECTIVES: The risk of Post-COVID-19 condition (PCC) under hybrid immunity remains unclear. METHODS: Using data from the German National Cohort (NAKO Gesundheitsstudie), we investigated risk factors for self-reported post-infection symptoms (any PCC is defined as having at least one symptom, and high symptom burden PCC as having nine or more symptoms). RESULTS: Sixty percent of 109,707 participants reported at least one previous SARS-CoV-2 infection; 35% reported having had any symptoms 4-12 months after infection; among them 23% reported nine or more symptoms. Individuals, who did not develop PCC after their first infection, had a strongly reduced risk for PCC after their second infection (50%) and a temporary risk reduction, which waned over nine months after the preceding infection. The risk of developing PCC strongly depended on the virus variant. Within variants, there was no effect of the number of preceding vaccinations, apart from a strong protection by the fourth vaccination compared to three vaccinations for the Omicron variant (odds ratio=0.52; 95% confidence interval 0.45-0.61). CONCLUSIONS: Previous infections without PCC and a fourth vaccination were associated with a lower risk of PCC after a new infection, indicating diminished risk under hybrid immunity. The two components of risk reduction after a preceding infection suggest different immunological mechanisms.

Impact Factor

Scopus SNIP

Altmetric

14.300

0.000